ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia in Adolescents and Young Adults
In recent years, recognition of the complex and variable management of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs), often drawing on both pediatric- and adult- inspired approaches, has highlighted the need for AYA-specific guidance.
ALL AYA Frontline Management
Dr. Wendy Stock, Chair of the ASH Acute Lymphoblastic Leukemia in Adolescents and Young Adults Frontline Management Guideline Panel from the University of Chicago, introduces ASH’s new guidelines on frontline management for adolescents and young adults with acute lymphoblastic leukemia (ALL). These recommendations are evidence-based and emphasize a collaborative, multidisciplinary approach to improving care quality and outcomes.
ALL AYA Relapsed Refractory
Dr. Kristen O’Dwyer, Chair of the ASH Acute Lymphoblastic Leukemia in Adolescents and Young Adults Relapsed/Refractory Guideline Panel from the University of Rochester Medical Center, discusses ASH’s new clinical practice guidelines focused on treating adolescents and young adults with relapsed or refractory acute lymphoblastic leukemia (ALL). These evidence-based recommendations are designed to enhance care quality through rigorous, multidisciplinary collaboration and patient-centered insights.